TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TELA TELA Bio, Inc.

Pre-Mkt 07-13 08:50:46 EDT

0.8470

-0.0110

-1.28%

High0.8599	Low0.8003	Vol66.83K
Open0.8003	D1 Closing0.8580	Amplitude6.95%
Mkt Cap37.92M	Tradable Cap16.94M	Total Shares44.77M
T/O55.13K	T/O Rate0.33%	Tradable Shares20.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TELA","market":"US","secType":"STK","nameCN":"TELA Bio, Inc.","latestPrice":0.847,"timestamp":1783713600000,"preClose":0.858,"halted":0,"volume":66826,"delay":0,"changeRate":-0.012820512820512832,"floatShares":20005600,"shares":44765928,"eps":-0.797672,"marketStatus":"Pre-Mkt","change":-0.011,"latestTime":"07-13 08:50:46 EDT","open":0.800301,"high":0.8599,"low":0.800301,"amount":55131.951195,"amplitude":0.069463,"askPrice":1.29,"askSize":200,"bidPrice":0.6864,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.797672,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783949400000},"marketStatusCode":1,"adr":0,"listingDate":1573189200000,"exchange":"NASDAQ","adjPreClose":0.847,"postHourTrading":{"tag":"盘后","latestPrice":0.8463,"preClose":0.847,"latestTime":"18:15 EDT","volume":413,"amount":349.6324,"timestamp":1783721703912,"change":-0.0007,"changeRate":-0.000826,"amplitude":0.000826},"volumeRatio":0.9034593876898462,"impliedVol":1.6637,"impliedVolPercentile":0.46},"requestUrl":"/m/hq/s/TELA/wiki","defaultTab":"wiki","newsList":[{"id":"2642823736","title":"TELA Bio director Joseph H. Capper files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642823736","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642823736?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:10","pubTimestamp":1781215848,"startTime":"0","endTime":"0","summary":"TELA Bio director Joseph H. Capper filed an initial Form 3 on June 11, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL40Fgl8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642840237","title":"TELA Bio director Guy P. Nohra files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642840237","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642840237?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:05","pubTimestamp":1781215557,"startTime":"0","endTime":"0","summary":"TELA Bio director Guy P. Nohra filed an initial Form 3 with the SEC on June 11, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLcgcCjF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642232602","title":"TELA Bio Shareholders Expand Equity Incentive Plan Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2642232602","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642232602?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:03","pubTimestamp":1781211837,"startTime":"0","endTime":"0","summary":"TELA Bio ( ($TELA) ) has shared an update. On June 9, 2026, TELA Bio stockholders approved an amendment to the company’s Amended and Restated 2019 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tela-bio-shareholders-expand-equity-incentive-plan-authorization?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tela-bio-shareholders-expand-equity-incentive-plan-authorization?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","BK4215","TELA","BK4588","BK4585","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642231125","title":"TELA Bio shareholders approve 3.5 million-share increase to equity incentive plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2642231125","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642231125?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:07","pubTimestamp":1781208427,"startTime":"0","endTime":"0","summary":"TELA Bio held its annual shareholder meeting on June 9, 2026.Shareholders endorsed an amendment to the Amended and Restated 2019 Equity Incentive Plan, adding 3,500,000 authorized shares.The plan amendment became effective immediately upon shareholder approval.Shareholders ratified KPMG as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL7SsBLs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635780045","title":"Lake Street Keeps Their Buy Rating on TELA Bio (TELA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635780045","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635780045?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:37","pubTimestamp":1778679431,"startTime":"0","endTime":"0","summary":"In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on TELA Bio, with a price target of $2.00. According to TipRank...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635500780","title":"Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635500780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635500780?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:10","pubTimestamp":1778677837,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fractyl-health-inc-guts-unitedhealth-unh-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fractyl-health-inc-guts-unitedhealth-unh-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1854103824.USD","BK4566","LU1989771016.USD","SG9999002232.USD","IE00B19Z8X17.USD","SG9999001176.USD","LU1934455863.HKD","LU1037948897.HKD","LU0266013472.USD","IE0009355771.USD","LU1674673691.USD","LU1718418525.SGD","LU0029864427.USD","LU2125154778.USD","LU0149725797.USD","LU0353189680.USD","LU0114720955.EUR","LU0316494557.USD","LU1934455194.USD","IE0005OL40V9.USD","IE00BFXG1179.USD","LU1119994496.HKD","LU0310800965.SGD","LU0029874061.USD","LU1720051108.HKD","LU1791710582.SGD","IE00BZ9MQY76.HKD","LU1720051017.SGD","LU0158827948.USD","IE000M9KFDE8.USD","IE00BKVL7J92.USD","IE00BFSS8Q28.SGD","SG9999018865.SGD","IE00B19Z3B42.SGD","LU2089283258.USD","IE00B775H168.HKD","LU1506573853.SGD","LU2125154935.USD","LU1496350502.SGD","IE00B4R5TH58.HKD","LU2023251221.USD","LU0158827781.USD","LU0557290698.USD","LU1791710400.SGD","IE00B1BXHZ80.USD","LU0820562030.AUD","LU1057294990.SGD","LU2244417387.USD","LU1066051225.USD","LU0861579265.USD","LU1551013425.SGD","IE0004445239.USD","LU2362541273.HKD","LU0238689110.USD","LU2461242641.AUD","LU0048584097.USD","SG9999014898.SGD","LU1074936037.SGD","LU0053666078.USD","LU0354030511.USD","LU0456855351.SGD","LU0795875086.SGD","LU0354030438.USD","LU1548497426.USD","LU1934455277.USD","LU0949170772.SGD","LU0965508806.USD","IE00B4JS1V06.HKD","LU0097036916.USD","LU0234572021.USD","SG9999014914.USD","IE0004445015.USD","BK4137","LU1854104046.USD","LU2362540622.SGD","LU2491050071.SGD","IE00B19Z3581.USD","SGXZ99366536.SGD","LU0107464264.USD","SG9999018857.SGD","SGXZ57979304.SGD","TELA","LU2111349929.HKD","LU1061106388.HKD","LU2552382058.USD","LU2552382132.HKD","LU0823416689.USD","LU1323610961.USD","IE00B1XK9C88.USD","LU2360032135.SGD","BK4581","LU0079474960.USD","LU2491049909.HKD","LU0211326755.USD","LU0128525929.USD","LU0094547139.USD","LU1066053197.SGD","IE00B19Z8W00.USD","LU2112291526.USD","LU2133065610.SGD","LU1983299246.USD","LU2242649171.HKD","LU2361045086.USD","SGXZ51526630.SGD","BK4154","LU1064131342.USD","IE00B2B36J28.USD","LU0256863811.USD","LU0708995401.HKD","LU0128525689.USD","LABU","LU1732799900.SGD","LU0912757837.SGD","XBI","IE00BJJMRY28.SGD","LU0787776722.HKD","LU2347655156.SGD","LU0689472784.USD","BK4532","IE00BJT1NW94.SGD","LU0965509283.SGD","IE00B7SZLL34.SGD","GUTS","LU0708994859.HKD","BK4082","LU0198837287.USD","LU0432979614.USD","LU1023059063.AUD","LU2491050154.USD","IE0002270589.USD","LU0345770993.USD","LU1003077747.HKD","LU0310800379.SGD","SG9999014906.USD","LU0211327993.USD","UNH","UNHG","IE00BWXC8680.SGD","LU0203345920.USD","LU0289739699.SGD","LU1551013342.USD","BK4198","LU2357305700.SGD","LU1670628061.USD","LU0672654240.SGD","LU0251132253.USD","LU0211326839.USD","LU1814569148.SGD","BK4533","SGXZ81514606.USD","LU1674673428.USD","BK4534","LU0052756011.USD","LU0417517546.SGD","LU0820561818.USD","LU1066051498.USD","LU0965509101.SGD","LU0496365809.HKD","LU0058720904.USD","LU0882574055.USD","LU1066051811.HKD","LU1267930490.SGD","LU0310799852.SGD","LU0528227936.USD","LU2211815571.USD","LU0187121727.USD","LU0320765059.SGD","LU0342679015.USD","LU0353189763.USD","LU1267930227.SGD","LU1732800096.USD","LU0545039389.USD","LU2028103732.USD","LU1153585028.USD","LU2087625088.SGD","LU2089984988.USD","LU1084165304.USD","BK4588","LU1670627923.USD","LU0128526141.USD","LU2362541513.USD","LU0122379950.USD","LU1914381329.SGD","LU2361044865.SGD","LU1069347547.HKD","IE00BN29S564.USD","SG9999017495.SGD","IE00BFTCPJ56.SGD","IE00BJJMRX11.SGD","LU0661504455.SGD","LU1035773651.USD","SG9999013999.USD","LU0553294199.USD","IE00B19Z9Z06.USD","LU0345770308.USD","IE00B19Z9P08.USD","LU0965509010.AUD","SGXZ31699556.SGD","IE00BKPKM429.USD","LU2264538146.SGD","IE00BSNM7G36.USD","LU2089284900.SGD","LU0943347566.SGD","LU2279689827.SGD","LU2468319806.SGD","LU0795875169.SGD","LU0683600562.USD","LU2552382215.SGD","SG9999001176.SGD","LU1267930573.SGD","LU2324357040.USD","LU2361044949.HKD","SG9999014880.SGD","LU0203347892.USD","LU1291159041.SGD","IE00B7KXQ091.USD","LU0820561909.HKD","LU2271345857.HKD","LU0109391861.USD","IE00BJJMRZ35.SGD","LU1037948541.HKD","LU1267930730.SGD","UNHW","SG9999002224.SGD","LU1988902786.USD","LU1261432733.SGD","IE00BFSS7M15.SGD","LU0011850046.USD","LU2236285917.USD","IE0002141913.USD","LU0976567544.SGD","LU1778281490.HKD","LU0077335932.USD","IE00B19Z9505.USD","LU0211328371.USD","BK4585","IE00B894F039.SGD","IE00BZ1G4Q59.USD","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635222805","title":"TELA Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635222805","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635222805?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:02","pubTimestamp":1778619726,"startTime":"0","endTime":"0","summary":"TELA Bio Inc reports results for the quarter ended March 31 - Earnings SummaryTELA Bio Inc TELA.OQ reported a quarterly adjusted loss of 21 cents per share for the quarter ended March 31, higher than ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P37K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635622804","title":"TELA Bio posts modest Q1 growth, maintains 2026 outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2635622804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635622804?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:43","pubTimestamp":1778618633,"startTime":"0","endTime":"0","summary":"An update from TELA Bio ( ($TELA) ) is now available. TELA Bio reported first quarter 2026 revenue of $19.1 million, a 3% increase year over year w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tela-bio-posts-modest-q1-growth-maintains-2026-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tela-bio-posts-modest-q1-growth-maintains-2026-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247782","title":"TELA Bio Q1 net loss widens to $12.3 million; revenue rises 3% to $19.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247782","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247782?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:12","pubTimestamp":1778616734,"startTime":"0","endTime":"0","summary":"TELA Bio posted first-quarter revenue of $19.1 million, up 3% year over year, while net loss widened to $12.3 million.Gross margin slipped 1.9 percentage points to 65.7% on a higher charge for excess and obsolete inventory as a percentage of revenue.Operating loss was $10.5 million as operating expenses held at $23.0 million; cash and cash equivalents totaled $39.5 million at March 31.European revenue growth accelerated 41% year over year; U.S. commercial launch of OviTex LTR began April 1.Full-year 2026 revenue guidance reiterated for at least 8% growth over 2025, with second-quarter revenue expected at about $20.0 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL1Vpmpx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU0314104364.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4585","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","TELA","LU2095319765.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4198","SG9999014021.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4112","SG9999014005.SGD","NDAQ","LU2210149790.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247612","title":"TELA Bio Q1 EPS $(0.21) Misses $(0.18) Estimate, Sales $19.059M Beat $18.597M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247612","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247612?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:07","pubTimestamp":1778616473,"startTime":"0","endTime":"0","summary":"TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 16 percent increase over losses of $(0.25) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52505734/tela-bio-q1-eps-0-21-misses-0-18-estimate-sales-19-059m-beat-18-597m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TELA Bio Q1 EPS $(0.21) Misses $(0.18) Estimate, Sales $19.059M Beat $18.597M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247592","title":"BRIEF-TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247592","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247592?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616347,"startTime":"0","endTime":"0","summary":"BRIEF-TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million\n\n\nMay 12 (Reuters) - TELA Bio Q1 income from operations USD -10.526 million.\n\nQ1 net income USD -12.273 million\nQ1 operating expenses USD 23.046 million\nQ1 basic EPS USD -0.21\nQ1 gross profit USD 12.52 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLXA7DA53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247817","title":"TELA Bio Q1 Income From Operations USD -10.526 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247817","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247817?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLXA7DA53:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635240594","title":"TELA Bio Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240594","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240594?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., May  12, 2026  (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293358/0/en/TELA-Bio-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634498957","title":"TELA Bio Inc  expected to post a loss of 19 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634498957","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634498957?lang=en_us&edition=fundamental","pubTime":"2026-05-09 06:55","pubTimestamp":1778280909,"startTime":"0","endTime":"0","summary":"TELA Bio Inc  expected to post a loss of19cents a share - Earnings Preview TELA Bio Inc TELA.OQ TELA.O is expected to  show a rise in quarterly revenue when it reports  results on May 12 for the perio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2V8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633217431","title":"TELA Bio grants 89,250 restricted stock units to 12 new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2633217431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633217431?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:26","pubTimestamp":1778185569,"startTime":"0","endTime":"0","summary":"TELA Bio set inducement grants of restricted stock units covering 89,250 common shares for 12 newly hired employees, with grant date May 5, 2026.Awards vest in equal annual installments over four years, contingent on continued service through each vesting date.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL36tFVJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","TELA","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4585","IE00BKPKM429.USD","NDAQ","BK4198","BK4588","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","BK4112","SG9999014021.USD","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014039.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633970176","title":"TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633970176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633970176?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184314,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUABYSHWF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632643033","title":"Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Irhythm Technologies (IRTC) and TELA Bio (TELA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632643033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632643033?lang=en_us&edition=fundamental","pubTime":"2026-05-01 23:41","pubTimestamp":1777650078,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY), Irhythm Technologies (IRTC) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-irhythm-technologies-irtc-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-irhythm-technologies-irtc-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","LU2028103732.USD","LU0787776722.HKD","LU1023059063.AUD","LU2471134879.HKD","IE0005OL40V9.USD","LU2417539215.USD","LU0106261372.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0128526141.USD","LU0640476718.USD","LU1551013342.USD","LU2237443895.HKD","LU1551013425.SGD","LU2746668461.USD","SG9999018857.SGD","LU0823434740.USD","LU2491050154.USD","LU0320765992.SGD","LU0889565916.HKD","SGXZ99366536.SGD","LU0234572021.USD","LU2168564495.EUR","SG9999015978.USD","SGXZ57979304.SGD","SG9999017495.SGD","LU0320765059.SGD","SG9999015986.USD","LU0354030438.USD","LU2552382215.SGD","LU2106854487.HKD","LU0820561909.HKD","LU2089984988.USD","IE00B1XK9C88.USD","BK4198","LU1720051017.SGD","LU0708995401.HKD","LU0417517546.SGD","SG9999013999.USD","LU2361045086.USD","LU0094547139.USD","LU2357305700.SGD","LU2461242641.AUD","BK4007","LU0471298694.HKD","LU0689472784.USD","LU1868837136.USD","LU1064131342.USD","LU2168564149.EUR","LU1267930730.SGD","BK4534","LU1280957306.USD","LU2237443465.HKD","SG9999018865.SGD","IE0004445239.USD","LU0323591593.USD","LU0029874061.USD","LU2213496289.HKD","LLYZ","LU2746668974.SGD","LU1989771016.USD","IRTC","LU2265009873.SGD","LU1868836914.USD","TELA","LU0432979614.USD","LU2361044865.SGD","LU1868836757.USD","LU2468319806.SGD","LU1323610961.USD","SG9999014914.USD","LU0964807845.USD","LU0316494557.USD","IE00B7KXQ091.USD","LU2168564222.USD","LU0198837287.USD","LU0158827948.USD","IE00BJT1NW94.SGD","LU0672654240.SGD","BK4137","BK4599","IE00BFSS7M15.SGD","LU1814569148.SGD","LU1868837300.USD","LU2361044949.HKD","LU1720051108.HKD","XBI","SG9999014880.SGD","SG9999015952.SGD","LU0203202063.USD","SG9999001176.SGD","LU2089283258.USD","LU1623119135.USD","IE00BJJMRY28.SGD","LU0006306889.USD","LU0820562030.AUD","SGXZ51526630.SGD","IE0009355771.USD","LU0114720955.EUR","LU2750360997.AUD","IE00BKPKM429.USD","LU2087625088.SGD","SG9999014898.SGD","LU1232071149.USD","LU2491050071.SGD","LU0158827781.USD","LU2471134952.CNY","LU2168563687.JPY","LU2023250330.USD","LU0210536198.USD","LU1035775433.USD","LU2237443622.USD","LU1629891620.HKD","LU1145028129.USD","LU2023250504.SGD","LU2023251221.USD","LU2063271972.USD","LU0079474960.USD","LU1917777945.USD","LU2756315664.SGD","LU0203201768.USD","LU0109391861.USD","LU2237443382.USD","LU1868836591.USD","LU0820561818.USD","LU2271345857.HKD","IE0004445015.USD","LU1974910355.USD","LU0109394709.USD","LU1069344957.HKD","LU0238689110.USD","LU2237438978.USD","IE00BN29S564.USD","LU1804176565.USD","LU0061475181.USD","IE00B2B36J28.USD","LU2236285917.USD","SG9999001176.USD","LU2456880835.USD","LU0097036916.USD","LU0823416689.USD","LLY","LU0122379950.USD","LU2471134523.USD","ELIL","LU2471134796.USD","LU2756315318.SGD","BK4585","BK4588","LU1093756325.SGD","LU0289739699.SGD","IE00B4JS1V06.HKD","LLYX","SGXZ31699556.SGD","LU0683600562.USD","IE00B775H168.HKD","LU0456855351.SGD","LU2237443549.SGD","LU0786609619.USD","LU0353189763.USD","LU2112291526.USD","LU2491049909.HKD","LABU","LU0882574055.USD","GB00BDT5M118.USD","IE00BK4W5M84.HKD","LU2462157665.USD","LU0256863811.USD","BK4082","SG9999015945.SGD","BK4581","LU0882574139.USD","LU0943347566.SGD","IE00BJJMRX11.SGD","LU2089284900.SGD","LLII","LU2896262040.SGD","LU0058720904.USD","SGXZ81514606.USD","LU1057294990.SGD","LU0354030511.USD","LU0133085943.USD","LU2237443978.SGD","LU2552382058.USD","LU0385154629.USD","IE00BJLML261.HKD","LU2168564065.EUR","IE00BWXC8680.SGD","LU0256863902.USD","LU1988902786.USD","LU2264538146.SGD","LU2602419157.SGD","LU0471298777.SGD","IE00BJJMRZ35.SGD","SG9999014906.USD","LU2108987350.USD","LU1712237335.SGD","IE00BFTCPJ56.SGD","LU2750360641.GBP","LU0266013472.USD","LU1548497426.USD","IE00BKDWB100.SGD","LU0823434583.USD","LU0466842654.USD","LU1127390331.HKD","LU1983299246.USD","LU2552382132.HKD","BK4563","IE00B1BXHZ80.USD","LU0096364046.USD","LU1061106388.HKD","LU2324357040.USD","IE0001KFT4U8.USD","BK4516","LU1093756168.USD","LU2111349929.HKD","IE00BK4W5L77.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU1291159041.SGD","LU0225283273.USD","LU1366192091.USD","ELIS","BK4533","LU0353189680.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632606926","title":"TELA Bio Reshapes Board, Appoints New Chairman, Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2632606926","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632606926?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:30","pubTimestamp":1777588240,"startTime":"0","endTime":"0","summary":"TELA Bio ( ($TELA) ) has provided an update. On April 29, 2026, TELA Bio announced a major reshaping of its board, with Chairman Doug Evans opting ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tela-bio-reshapes-board-appoints-new-chairman-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tela-bio-reshapes-board-appoints-new-chairman-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632620386","title":"TELA Bio sees Q1 revenue about $19 million, above prior $18.5 million view","url":"https://stock-news.laohu8.com/highlight/detail?id=2632620386","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632620386?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:02","pubTimestamp":1777586560,"startTime":"0","endTime":"0","summary":"TELA Bio flagged preliminary Q1 2026 revenue of about $19 million.Prior outlook called for revenue of about $18.5 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief on April 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL1MlWgn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632662825","title":"TELA Bio names Joseph Capper board chair in four-director refreshment plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2632662825","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632662825?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:30","pubTimestamp":1777584603,"startTime":"0","endTime":"0","summary":"TELA Bio set a board refreshment plan tied to 2026 annual meeting on June 9, with four directors slated to step down.Chairman Doug Evans will exit board, alongside Kurt Azarbarzin, Vince Burgess, Federica O’Brien.Joseph Capper, CEO of MiMedx since January 2023, will be nominated as Class I director, expected to become board chair upon election.Board added Guy Nohra, Alta Partners co-founder, as Class II director.Appointments also include Joseph Neels, EW Healthcare Partners operating partner, and Paul Thomas, Prominex CEO and co-founder, as Class III directors.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL4d5SMR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4112","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","TELA","SG9999014039.USD","IE00BN0W2T93.GBP","BK4139","SG9999014021.USD","MDXG","BK4585","BK4588","NDAQ","BK4198","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telabio.com","stockEarnings":[{"period":"1week","weight":0.1741},{"period":"1month","weight":-0.1009},{"period":"3month","weight":0.4928},{"period":"6month","weight":-0.2229},{"period":"1year","weight":-0.5908},{"period":"ytd","weight":-0.2822}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1111},{"period":"6month","weight":0.0877},{"period":"1year","weight":0.2063},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.024622},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.021438},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.222765},{"month":4,"riseRate":0.285714,"avgChangeRate":0.009305},{"month":5,"riseRate":0.857143,"avgChangeRate":0.115004},{"month":6,"riseRate":0.428571,"avgChangeRate":0.019526},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.013939},{"month":8,"riseRate":0.5,"avgChangeRate":-0.029417},{"month":9,"riseRate":0.5,"avgChangeRate":-0.04117},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.071357},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.011933},{"month":12,"riseRate":0.571429,"avgChangeRate":0.074086}],"exchange":"NASDAQ","name":"TELA Bio, Inc.","nameEN":"TELA Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TELA Bio, Inc.,TELA,TELA Bio, Inc.股票,TELA Bio, Inc.股票老虎,TELA Bio, Inc.股票老虎国际,TELA Bio, Inc.行情,TELA Bio, Inc.股票行情,TELA Bio, Inc.股价,TELA Bio, Inc.股市,TELA Bio, Inc.股票价格,TELA Bio, Inc.股票交易,TELA Bio, Inc.股票购买,TELA Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction